Physician

Alaine Evelyn Gada, MD

According to 2025 Medicare claims, Alaine Gada, MD (NPI: 1871794339) practices nephrology in the Harrisburg-Carlisle, PA market, with the plurality of this provider's patient population coming from Cumberland, PA. This provider's primary affiliated billing organization is KIDNEY CARE SPECIALISTS LLC (NPI: 1962992404; TIN: 82-4435212) and primary practice location at 17011-2308.

Gada's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 288 traditional Medicare patients, billed 1,035 HCPCS/CPT codes, and received $46,092 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,316 prescription claims across 252 beneficiaries totaling $106,035 in drug costs, led by Veltassa (Patiromer Calcium Sorbitex). DME data shows 13 claims. Open Payments data shows 8 records totaling $164. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $65,181 and ending at $46,092. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,931 to $106,035. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	390	899	$65,181
2016	308	592	$50,928
2017	204	734	$83,306
2018	146	266	$29,372
2019	227	450	$37,768
2020	215	402	$35,007
2021	253	471	$45,476
2022	362	562	$49,242
2023	279	1,115	$38,480
2024	288	1,035	$46,092

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	14	41	$2,931
2016	23	51	$29,227
2017	67	334	$37,867
2018	68	298	$20,623
2019	99	441	$23,622
2020	104	511	$29,255
2021	133	619	$30,343
2022	157	746	$44,389
2023	229	1,034	$69,446
2024	252	1,316	$106,035

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	13	$160

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	49	49	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	156	246	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	163	226	$54
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	28	90	$43
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	144	258	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Veltassa	Patiromer Calcium Sorbitex	15	978	$29,048
Farxiga	Dapagliflozin Propanediol	26	930	$17,574
Lokelma	Sodium Zirconium Cyclosilicate	14	540	$13,821
Potassium Citrate Er	Potassium Citrate	35	2,595	$4,836
Hydralazine Hcl	Hydralazine Hcl	132	8,788	$1,885

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	13	$160

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$164	Vifor Pharma, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alaine Evelyn Gada, MD?

Tedicare shows public-source Medicare data for Alaine Evelyn Gada, MD (NPI 1871794339), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alaine Evelyn Gada, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alaine Evelyn Gada, MD?

Alaine Evelyn Gada, MD is linked to KIDNEY CARE SPECIALISTS LLC (billing NPI 1962992404) in the available physician profile data.

Does Alaine Evelyn Gada, MD have Open Payments data?

Alaine Evelyn Gada, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.